[ACRX] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
09-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -8.89%
YoY- -17.96%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 442 511 386 265 343 3,109 3,025 -27.41%
PBT -8,674 -8,956 -15,925 -13,674 -11,592 -15,551 -10,979 -3.84%
Tax -321 858 843 627 136 -2,704 2 -
NP -8,353 -8,956 -15,925 -13,674 -11,592 -15,551 -10,981 -4.45%
Tax Rate - - - - - - - -
Total Cost 8,795 9,467 16,311 13,939 11,935 18,660 14,006 -7.45%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -1,889.82 -1,752.64 -4,125.65 -5,160.00 -3,379.59 -500.19 -363.01 31.63%
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -1.15 -1.58 -3.98 -3.47 -4.55 -6.86 -4.85 -21.31%
EPS Diluted -1.15 -1.58 -3.98 -3.47 -4.55 -6.86 -4.85 -21.31%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.